Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Scott Rocklage


  • Large Shareholder at Cabaletta Bio Inc. (CABA), 2019-10-31
  • at Aprea Therapeutics Inc. (APRE), 2019-10-07
  • Large Shareholder at Arvinas Inc. (ARVN), 2019-09-19
  • Other at Crinetics Pharmaceuticals Inc. (CRNX), 2019-06-25
  • Large Shareholder at Ideaya Biosciences Inc. (IDYA), 2019-05-29
  • Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-20
  • Director at Cidara Therapeutics Inc. (CDTX), 2018-06-16
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2017-11-22
  • Other at Audentes Therapeutics Inc. (BOLD), 2017-04-27
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-23
  • Director at Pulmatrix Inc. (PULM), 2015-06-25
  • Large Shareholder, Director at Epirus Biopharmaceuticals Inc. (EPRS), 2015-06-08
  • Large Shareholder at Viveve Medical Inc. (VIVMF), 2015-05-29
  • Director at Achaogen Inc (AKAO), 2014-03-13
  • Large Shareholder, Director at Relypsa Inc (RLYP), 2013-11-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PULM $6.88 4,815 Director 168,873 2015-06-16 Filing
PULM $6.88 33,990 Director 1,192,154 2015-06-16 Filing
EPRS $5.00 389,950 Large Shareholder, Director 2,549,211 2015-02-04 Filing
EPRS $5.00 10,050 Large Shareholder, Director 65,699 2015-02-04 Filing
RLYP $11.00 9,364 Large Shareholder, Director 62,316 2013-11-20 Filing